Inside Track: Advancing Clinical Sequencing
A new partnership promises a focus on patient applications.
Read MorePosted by Steve Halasey | Oct 11, 2019 | Allergy & Autoimmune, Infectious Diseases, Molecular Diagnostics, Research |
A new partnership promises a focus on patient applications.
Read MorePosted by Steve Halasey | Oct 8, 2019 | Breast |
The Ventana PD-L1 assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy.
Read MorePosted by Steve Halasey | Oct 1, 2019 | Research |
RightEye’s technology quickly delivers precise eye-movement data by surveying the eye several times per second and recording its movements.
Read MorePosted by Steve Halasey | Sep 24, 2019 | Pancreatic |
Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.
Read MorePosted by Steve Halasey | Sep 24, 2019 | Cerebrovascular, Research, Stroke |
Developers say the technology could help accelerate the discovery and development of new anticlotting therapies.
Read More